UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemoprotective and radioprotective effects of amifostine : An update of clinical trials

International journal of hematology, 2000-12, Vol.72 (4), p.425-435

2000

Volltextzugriff (PDF)

Nature Connection, Mindfulness, and Wellbeing: A Network Analysis

OBM Integrative and Complementary Medicine, 2023-11, Vol.8 (4), p.1-46

2023

Volltextzugriff (PDF)

Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux

Leukemia research, 2008-03, Vol.32 (3), p.465-473

2008

Volltextzugriff (PDF)

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia

Leukemia research, 2010-04, Vol.34 (4), p.487-491

2010

Volltextzugriff (PDF)

Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas

Transactions of the American Clinical and Climatological Association, 2004, Vol.115, p.255-272

Capizzi, Robert L

2004

Volltextzugriff (PDF)

Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer

The New England journal of medicine, 1991-11, Vol.325 (19), p.1342-1348

1991

Volltextzugriff (PDF)

Abstract 4623: Human anti-nucleolin antibodies with broad spectrum anticancer activity

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4623-4623

2012

Volltextzugriff (PDF)

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

Blood, 2005-06, Vol.105 (12), p.4576-4582

2005

Volltextzugriff (PDF)

Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor ( EGFR ) activating mutation(s)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS8123-TPS8123

2013

Volltextzugriff (PDF)

Amifostine‐mediated protection of normal bone marrow from cytotoxic chemotherapy

Cancer, 1993-12, Vol.72 (S11), p.3495-3501

1993

Volltextzugriff (PDF)

Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram

Journal of computer assisted tomography, 2001-07, Vol.25 (4), p.624-628

2001

Volltextzugriff (PDF)

Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedside

Investigational new drugs, 1996-01, Vol.14 (3), p.249-256

Capizzi, R L

1996

Volltextzugriff (PDF)

Clinical status and optimal use of amifostine

Oncology (Williston Park, N.Y.), 1999-01, Vol.13 (1), p.47

Capizzi, R L

1999

Volltextzugriff (PDF)

Stimulation of Hematopoiesis by Amifostine in Patients With Myelodysplastic Syndrome

Blood, 1997-11, Vol.90 (9), p.3364-3369

1997

Volltextzugriff (PDF)

Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease

Obstetrics and gynecology (New York. 1953), 1988-09, Vol.72 (3 Pt 1), p.413

1988

Volltextzugriff (PDF)

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study

Blood, 2009-11, Vol.114 (22), p.1047-1047

2009

Volltextzugriff (PDF)

Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML

Blood, 2008-11, Vol.112 (11), p.2968-2968

2008

Volltextzugriff (PDF)

Ether-linked phosphoglyceride content of human Leukemia cells

Cancer research (Chicago, Ill.), 1990-11, Vol.50 (22), p.7174-7178

1990

Volltextzugriff (PDF)

1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats

Stroke (1970), 1999-09, Vol.30 (9), p.1907-1915

1999

Volltextzugriff (PDF)

Recent Developments and Emerging Options: The Role of Amifostine as a Broad-Spectrum Cytoprotective Agent

Seminars in oncology, 1999-04, Vol.26 (2), p.1-2

CAPIZZI, Robert L

1999

Volltextzugriff (PDF)

Leukemia: experimental and preclinical studies

Current opinion in oncology, 1990-02, Vol.2 (1), p.10-17

Capizzi, Robert L

1990

Volltextzugriff (PDF)

Amifostine improves the antileukemic therapeutic index of mafosfamide : implications for bone marrow purging

Blood, 1995-10, Vol.86 (7), p.2849-2855

1995

Volltextzugriff (PDF)

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

Cancer, 1979-10, Vol.44 (4), p.1189-1193

1979

Volltextzugriff (PDF)

Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability

Cancer research (Chicago, Ill.), 1982-05, Vol.42 (5), p.1641-1645

1982

Volltextzugriff (PDF)

A Novel N-Oxide Drug, AQ4N, Has In Vitro Activity in Lymphoma and Leukemia Cell Lines and Selectively Targets Lymphocytes and Lymphatic Tissues in Vivo

Blood, 2004-11, Vol.104 (11), p.2498-2498

2004

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(113)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(75)
Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Oncology
(44)
Biological And Medical Sciences
(43)
Female
(43)
Medical Sciences
(42)
Middle Aged
(39)
Male
(37)
Pharmacology. Drug Treatments
(34)
Adult
(31)
Aged
(29)
Antineoplastic Agents
(27)
Animals
(26)
Chemotherapy
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Cytarabine - Administration & Dosage
(16)
Time Factors
(16)
Mice
(14)
Leukemia - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemoprotective and radioprotective effects of amifostine : An update of clinical trials

Nature Connection, Mindfulness, and Wellbeing: A Network Analysis

Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia

Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas

Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer

Abstract 4623: Human anti-nucleolin antibodies with broad spectrum anticancer activity

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor ( EGFR ) activating mutation(s)

Amifostine‐mediated protection of normal bone marrow from cytotoxic chemotherapy

Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram

Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedside

Clinical status and optimal use of amifostine

Stimulation of Hematopoiesis by Amifostine in Patients With Myelodysplastic Syndrome

Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study

Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML

Ether-linked phosphoglyceride content of human Leukemia cells

1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats

Recent Developments and Emerging Options: The Role of Amifostine as a Broad-Spectrum Cytoprotective Agent

Leukemia: experimental and preclinical studies

Amifostine improves the antileukemic therapeutic index of mafosfamide : implications for bone marrow purging

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability

A Novel N-Oxide Drug, AQ4N, Has In Vitro Activity in Lymphoma and Leukemia Cell Lines and Selectively Targets Lymphocytes and Lymphatic Tissues in Vivo

Suchergebnisse filtern